Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-28 @ 1:08 AM
Study NCT ID:
NCT01023204
Status:
COMPLETED
Last Update Posted:
2010-02-04
First Post:
2009-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2005-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-30
First Submit QC Date:
None
Study First Post Date:
2009-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-02-02
Last Update Post Date:
2010-02-04
Last Update Post Date Type:
ESTIMATED